GlaxoSmithKline
STANFORD, Calif. -- Many patients with diabetes should forego angioplasties for heart disease and just take medicine instead, according to a new National Institutes of Health study led by Stanford University School of Medicine researcher Mark Hlatky, MD.
BENLYSTA™ Successful in Second Pivotal Clinical Trial
NAIROBI, Kenya, November 2, 2009 -- Marking its tenth anniversary year, the PATH Malaria Vaccine Initiative (MVI) today unveiled a new strategy that sets the stage for an aggressive push targeting
STANFORD, Calif. -- Two common anti-influenza drugs -- Relenza and Tamiflu -- appear equally effective at preventing common flu symptoms when given before infection, say researchers from the Stanford University School of Medicine.
NEW ORLEANS, June 7 -- There is no difference in mortality among patients with type 2 diabetes and stable heart disease who received prompt bypass surgery or angioplasty compared to drug therapy alone, according to a landmark study focused exclusively on patients with both conditions.
NEW YORK (March 20, 2009) -- Patients suffering from a blood disorder that prevents proper clotting have the option of a new medication that may dramatically improve their health. There are estimated to be between 50,000 and 100,000 individuals in the U.S.
Schizophrenia could be caused by faulty signalling in the brain, according to new research published today in the journal Molecular Psychiatry. In the biggest study of its kind, scientists looking in detail at brain samples donated by people with the condition have identified 49 genes that work differently in the brains of schizophrenia patients compared to controls.
Zinc is an essential element for a healthy body. Zinc is involved in numerous aspects of cellular metabolism (National Institute of Health). According to Food and Nutrition Board, zinc is also essential in for proper taste and smell. The recommended daily allowance for adult males is 11mg and 8mg for female adults. Adults are above the age 19 y.o.
A new vaccine, made with several proteins from the bacterium that causes tuberculosis (TB), will soon enter the first phase of human safety testing. The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has supported research on the candidate vaccine from its earliest stages. The trial will be conducted in the United States by Seattle biotechnology company Corixa and GlaxoSmithKline Biologicals, a vaccine manufacturer headquartered in Belgium.
Breast cancer tumors that stop responding to the drug tamoxifen actually change their cellular characteristics and become responsive to other types of drugs, including Herceptin, according to oncologists at the Duke Comprehensive Cancer Center. "In the process of becoming resistant to tamoxifen, the tumors alter their qualities and become receptive to Herceptin and other drugs that target the HER-2 receptor," said Kimberly Blackwell, M.D., assistant professor of oncology at Duke.
Nearly 20 percent of smokers using an over-the-counter nicotine patch in a new study were able to quit smoking entirely after six weeks, compared to only 7 percent of smokers using a dummy patch. Each group reported only mild side effects from patch use, like rashes or insomnia. None of the smokers received any direct instruction on how to use the patch or got behavioral counseling to help them quit smoking, which suggests that nicotine patches used in an over-the-counter manner can be safe and effective, say the study authors. The study was supported by GlaxoSmithKline Consumer Healthcare, which markets the NicoDerm CQ patch.
The U.S. Food and Drug Administration has approved a nicotine throat lozenge meant to help smokers kick the habit. The sweets will be sold in stores alongside similar gums and patches. Maker GlaxoSmithKilne says the over-the-counter lozenges will come in two strengths to provide smokers with a source of nicotine that helps them avoid cigarette cravings and withdrawal symptoms while they try to quit.
